Invention Grant
US08148332B2 Method for treating a rheumatic disease using a soluble TLA4 molecule
有权
使用可溶性CTLA4分子治疗风湿性疾病的方法
- Patent Title: Method for treating a rheumatic disease using a soluble TLA4 molecule
- Patent Title (中): 使用可溶性CTLA4分子治疗风湿性疾病的方法
-
Application No.: US13191923Application Date: 2011-07-27
-
Publication No.: US08148332B2Publication Date: 2012-04-03
- Inventor: Robert Cohen , Suzette Carr , David Hagerty , Robert James Peach , Jean-Claude Becker
- Applicant: Robert Cohen , Suzette Carr , David Hagerty , Robert James Peach , Jean-Claude Becker
- Applicant Address: US NJ Princeton
- Assignee: Bristol-Myers Squibb Company
- Current Assignee: Bristol-Myers Squibb Company
- Current Assignee Address: US NJ Princeton
- Agent Nickki L. Parlet
- Main IPC: A61K38/16
- IPC: A61K38/16
Abstract:
The present invention relates to compositions and methods for treating rheumatic diseases, such as psoriasis arthropathica, by administering to a subject a CTLA4 molecule that block endogenous B7 molecules from binding their ligands.
Public/Granted literature
- US20110311529A1 METHOD FOR TREATING A RHEUMATIC DISEASE USING A SOLUBLE TLA4 MOLECULE Public/Granted day:2011-12-22
Information query
IPC分类:
